Literature DB >> 16381023

Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer.

Bernd Frank, Kari Hemminki, Barbara Wappenschmidt, Rüdiger Klaes, Alfons Meindl, Rita K Schmutzler, Peter Bugert, Michael Untch, Claus R Bartram, Barbara Burwinkel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16381023     DOI： 10.1002/ijc.21696

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  9 in total

1.  Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells.

Authors:  Lian Yang; Jun He; Libo Chen; Guobin Wang
Journal:  Med Oncol       Date:  2008-12-13       Impact factor: 3.064

2.  Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration.

Authors:  Li-Bo Chen; Jun-Yao Xu; Zhen Yang; Guo-Bin Wang
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

Review 3.  Epigenetic aberrations and cancer.

Authors:  Miryam Ducasse; Mark A Brown
Journal:  Mol Cancer       Date:  2006-11-08       Impact factor: 27.401

4.  Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study.

Authors:  Barbara Burwinkel; Kalai S Shanmugam; Kari Hemminki; Alfons Meindl; Rita K Schmutzler; Christian Sutter; Barbara Wappenschmidt; Marion Kiechle; Claus R Bartram; Bernd Frank
Journal:  BMC Cancer       Date:  2006-11-17       Impact factor: 4.430

5.  Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral infection.

Authors:  D E de Almeida Nagata; H-A Ting; K A Cavassani; M A Schaller; S Mukherjee; C Ptaschinski; S L Kunkel; N W Lukacs
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

6.  Proper Activity of Histone H3 Lysine 4 (H3K4) Methyltransferase Is Required for Morphogenesis during Zebrafish Cardiogenesis.

Authors:  Jun-Dae Kim; Eunmi Kim; Soonil Koun; Hyung-Jin Ham; Myungchull Rhee; Myoung-Jin Kim; Tae-Lin Huh
Journal:  Mol Cells       Date:  2015-05-22       Impact factor: 5.034

7.  C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis.

Authors:  Mark A Brown; Kenneth Foreman; June Harriss; Chhaya Das; Li Zhu; Melissa Edwards; Salam Shaaban; Haley Tucker
Journal:  Oncotarget       Date:  2015-02-28

8.  SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer.

Authors:  Ting-Ting Liu; Hui Xu; Wei-Ping Gao; Shu-Xiang Zhang; Xu-Hong Zhou; Juan Tang; Qiong-Na Liu
Journal:  Med Sci Monit       Date:  2016-12-26

9.  Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer.

Authors:  Xiang Wu; Qingjiang Xu; Pingzhou Chen; Chenbo Yu; Liefu Ye; Chen Huang; Tao Li
Journal:  Cancer Manag Res       Date:  2019-09-02       Impact factor: 3.989
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.